| pubmed-article:19609464 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19609464 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
| pubmed-article:19609464 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:19609464 | lifeskim:mentions | umls-concept:C2709270 | lld:lifeskim |
| pubmed-article:19609464 | lifeskim:mentions | umls-concept:C0039593 | lld:lifeskim |
| pubmed-article:19609464 | lifeskim:mentions | umls-concept:C0015219 | lld:lifeskim |
| pubmed-article:19609464 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:19609464 | pubmed:dateCreated | 2009-7-17 | lld:pubmed |
| pubmed-article:19609464 | pubmed:abstractText | The use of natriuretic peptide testing has expanded considerably over the recent years. Thanks to clinical trials that have demonstrated significant benefits associated with testing for B-type natriuretic peptide (BNP) and its amino-terminal pro-peptide (NTproBNP), testing for these peptides is now ubiquitous in modern medicine. This review will focus on the use of NTproBNP in clinical medicine, with a discussion of the biologic significance of NT-proBNP, its proven present uses and potential future applications. | lld:pubmed |
| pubmed-article:19609464 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19609464 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19609464 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19609464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19609464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19609464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19609464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19609464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19609464 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19609464 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:19609464 | pubmed:issn | 0214-0934 | lld:pubmed |
| pubmed-article:19609464 | pubmed:author | pubmed-author:JanuzziJames... | lld:pubmed |
| pubmed-article:19609464 | pubmed:author | pubmed-author:Bayes-GenisAn... | lld:pubmed |
| pubmed-article:19609464 | pubmed:copyrightInfo | Copyright 2009 Prous Science, S.A.U. or its licensors. All rights reserved. | lld:pubmed |
| pubmed-article:19609464 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19609464 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:19609464 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19609464 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19609464 | pubmed:pagination | 267-73 | lld:pubmed |
| pubmed-article:19609464 | pubmed:meshHeading | pubmed-meshheading:19609464... | lld:pubmed |
| pubmed-article:19609464 | pubmed:meshHeading | pubmed-meshheading:19609464... | lld:pubmed |
| pubmed-article:19609464 | pubmed:meshHeading | pubmed-meshheading:19609464... | lld:pubmed |
| pubmed-article:19609464 | pubmed:meshHeading | pubmed-meshheading:19609464... | lld:pubmed |
| pubmed-article:19609464 | pubmed:meshHeading | pubmed-meshheading:19609464... | lld:pubmed |
| pubmed-article:19609464 | pubmed:meshHeading | pubmed-meshheading:19609464... | lld:pubmed |
| pubmed-article:19609464 | pubmed:meshHeading | pubmed-meshheading:19609464... | lld:pubmed |
| pubmed-article:19609464 | pubmed:meshHeading | pubmed-meshheading:19609464... | lld:pubmed |
| pubmed-article:19609464 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19609464 | pubmed:articleTitle | Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure. | lld:pubmed |
| pubmed-article:19609464 | pubmed:affiliation | Cardiology Division, Massachusetts General Hospital, 55 Fruit Street, Yawkey 5984, Boston, Massachusetts 02114, USA. JJanuzzi@partners.org | lld:pubmed |
| pubmed-article:19609464 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19609464 | pubmed:publicationType | Review | lld:pubmed |
